Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus

Glazkova S, Golparian D, Titov L, Pankratova N, Suhabokava N, Shimanskaya I, Domeika M, Unemo M. Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus. APMIS 2011; 119: 537–42. Increased antimicrobial resistance (AMR) in Nei...

Full description

Saved in:
Bibliographic Details
Published inAPMIS : acta pathologica, microbiologica et immunologica Scandinavica Vol. 119; no. 8; pp. 537 - 542
Main Authors GLAZKOVA, SLAVYANA, GOLPARIAN, DANIEL, TITOV, LEONID, PANKRATOVA, NATALIYA, SUHABOKAVA, NATALIYA, SHIMANSKAYA, IRINA, DOMEIKA, MARIUS, UNEMO, MAGNUS
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2011
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glazkova S, Golparian D, Titov L, Pankratova N, Suhabokava N, Shimanskaya I, Domeika M, Unemo M. Antimicrobial susceptibility/resistance and molecular epidemiological characteristics of Neisseria gonorrhoeae in 2009 in Belarus. APMIS 2011; 119: 537–42. Increased antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a global concern, and ultimately gonorrhoea may become untreatable. Nonetheless, AMR data from East‐Europe are scarce beyond Russia, and no AMR data or other characteristics of gonococci have been reported from Belarus for more than 20 years. The aim was to describe the prevalence of AMR, and report molecular epidemiological characteristics of gonococci circulating in 2009 in Belarus. In a sample of 80 isolates, resistance prevalences to antimicrobials used for gonorrhoea treatment in Belarus were: Ceftriaxone 0%, spectinomycin 0%, azithromycin 17.3%, tetracycline 25.9%, ciprofloxacin 34.6% and erythromycin 59.2%. The isolates displayed no penA mosaic alleles, 38 porB gene sequences and 35 N. gonorrhoeae multiantigen sequence types, of which 20 have not been described before worldwide. Due to the high levels of antimicrobial resistance, only ceftriaxone and spectinomycin can be recommended for empirical treatment of gonorrhoea in Belarus according to WHO recommendations. Continuous gonococcal AMR surveillance in Eastern Europe is crucial. This is now initiated in Belarus using WHO protocols.
Bibliography:ArticleID:APM2770
ark:/67375/WNG-GJBWL1SW-6
istex:6591C8D9B7B7DCDD1BECCA076444D933CC504719
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0903-4641
1600-0463
1600-0463
DOI:10.1111/j.1600-0463.2011.02770.x